Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
FIT (fecal immunochemical testing), which tests for hidden blood in the stool, is an inexpensive home health test for colorectal cancer.
Braftovi plus Erbitux improved survival for people with previously treated advanced colorectal cancer.
New expert guidelines recommend that individuals of average risk for colorectal cancer begin screening exams at 45 instead of 50.
Women who frequently drank sugary beverages as adolescents were at particular risk of developing colon cancer before age 50.
The GI Genius aids clinicians in detecting potential irregularities during colon cancer screening and surveillance.
Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.
The response rate was nearly 50% for people with breast, colon, pancreatic and other cancers.
Researchers in Japan have found that cigarette smoking may increase the risk of colorectal cancer in a Japanese population.
Colorectal cancer in people under 50 has risen dramatically in recent decades.
A personalized blood test can detect colon cancer recurrence sooner than scans.
The Colon Cancer Foundation seeks new ways to keep people free from colorectal cancer. An interview with the new president, Cindy Borassi.
But this benefit applied only to those individuals who initiated aspirin use at an earlier age.
Tests for circulating tumor DNA can help predict which patients are more likely to relapse.
The decrease is largely due to improved lung cancer treatment, but the impact of COVID-19 is not yet known.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.